An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. The European Study Group of Community Acquired Pneumonia (ESOCAP) of the European Respiratory Society

Schaberg, T.; Gialdroni-Grassi, G.; Huchon, G.; Leophonte, P.; Manresa, F.; Woodhead, M.
October 1996
Thorax;Oct1996, Vol. 51 Issue 10, p1017
Academic Journal
No abstract available.


Related Articles

  • Management of community acquired lower respiratory tract infection. Hosker, Harold S.R.; Jones, Gail M.; Hawkey, Peter // BMJ: British Medical Journal (International Edition);3/12/94, Vol. 308 Issue 6930, p701 

    Focuses on the diagnosis and management of community acquired lower respiratory tract infection. Discussion of lower respiratory tract infection; Comparison between bronchitis and pneumonia; Considerations for diagnostic tests of patients with lower respiratory tract infection.

  • Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus. Hirsch, Hans H.; Martino, Rodrigo; Ward, Katherine N.; Boeckh, Michael; Einsele, Hermann; Ljungman, Per // Clinical Infectious Diseases;1/15/2013, Vol. 56 Issue 2, p258 

    Respiratory viruses have been recognized as a significant cause of morbidity and mortality in patients with leukemia and those undergoing hematopoietic stem cell transplantation. The risk for lower respiratory tract infections and a fatal outcome appears to depend on the intrinsic virulence of...

  • Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Community-Acquired Lower Respiratory Tract Infections. Principi, Nicola; Esposito, Susanna; Blasi, Francesco; Allegra, Luigi // Clinical Infectious Diseases;5/1/2001, Vol. 32 Issue 9, p1281 

    Deals with a study which investigated the role of Mycoplasma pneumoniae and Chlamydia pneumoniae in community-acquired lower respiratory tract infections in children. Patients and methods; Demographics of the research participants; Incidence of pneumoniae infections.

  • Isolation of Legionella pneumophila from clinical & environmental sources in a tertiary care hospital. Anbumani, S.; Gururajkumar, A.; Chaudhury, A. // Indian Journal of Medical Research;Jun2010, Vol. 131 Issue 6, p761 

    Background & objectives: Legionella pneumophila and other members of this genus are important respiratory pathogens but legionellosis often remains a neglected and under reported condition. Hence, this study was done to find out the presence of this organism in patients admitted to a tertiary...

  • Network addresses antiobiotic resistance.  // European Pharmaceutical Executive;May/Jun2006, p14 

    The article reports on the launch of scientific network called Genomics to Combat Resistance against Antibiotics in Community-acquired lower respiratory tract infections in Europe (GRACE) on March 2006. GRACE brings together 17 academic groups from European Union member states to ensure the...

  • Detection of Mycoplasma pneumoniae in children with lower respiratory tract infections. Maheshwari, Megha; Kumar, Surinder; Sethi, G. R.; Bhalla, P. // Tropical Doctor;Jan2011, Vol. 41 Issue 1, p40 

    Mycoplasma pneumoniae is known to be a major cause of lower respiratory tract infections (LRTIs) in children. We studied 75 children who had been hospitalized for community-acquired LRTIs for the detection of M. pneumoniae by serological analysis and polymerase chain reaction (PCR) to amplify a...

  • Oral versus intravenous antibiotics for community acquired lower respiratory tract infection... Chan, Robert; Hemeryck, Linda // BMJ: British Medical Journal (International Edition);5/27/95, Vol. 310 Issue 6991, p1360 

    Studies the difference in the outcome between patients treated with oral and intravenous antibiotics for community acquired lower respiratory tract infection. Criteria for the admission of infected patients; Definition of terms; Lack of significant differences between the groups; Shroter...

  • Incidence, mortality and economic consequences.  // Thorax;Dec2001 Supplement 4, Vol. 56, piv13 

    The article focuses on the incidence, mortality and economic consequences of community acquired pneumonia (CAP). The annual incidence in the community is 5-11 per 1000 adult population. CAP accounts for 5-12% of all cases of adult lower respiratory tract infection managed by general...

  • The Continuing Challenge of Lower Respiratory Tract Infections. Robert C.3 Moellering Jr. // Clinical Infectious Diseases;5/15/2004 Supplement, Vol. 38, pS319 

    The discovery and clinical application of antibiotics has markedly changed the management of a wide variety of respiratory tract infections, including community acquired pneumonia (CAP), during the past half-century. One of the factors that could account for the persistence of problematic...

  • ASSOCIATION OF MYCOPLASMA PNEUMONIAE WITH RESPIRATORY TRACT INFECTIONS IN CHILDREN. Abdul-Wahab, Osama Mohammed Saed; Al-Hakami, Ahmed Mossa; Shati, Ayed Abdullah; Alsuheel, Ali Mohammed; Kumar, Ashish; Benahmed, Fateha // American Journal of Immunology;2013, Vol. 9 Issue 1, p1 

    Mycoplasma pneumoniae is one of four most common species of organisms that are responsible for most clinically significant infections in humans. It is a frequent cause of acute respiratory infections in both children and adults. The organism can cause pharyngitis, otitis, tracheobronchitis, or...


Read the Article


Sign out of this library

Other Topics